{Reference Type}: Journal Article
{Title}: Biological variability hampers the use of skeletal staining methods in zebrafish embryo developmental toxicity assays.
{Author}: Hoyberghs J;Ball J;Trznadel M;Beekhuijzen M;Burbank M;Wilhelmi P;Muriana A;Powles-Glover N;Letamendia A;Van Cruchten S;
{Journal}: Reprod Toxicol
{Volume}: 127
{Issue}: 0
{Year}: 2024 Aug 28
{Factor}: 3.421
{DOI}: 10.1016/j.reprotox.2024.108615
{Abstract}: Zebrafish embryo assays are used by pharmaceutical and chemical companies as new approach methodologies (NAMs) in developmental toxicity screening. Despite an overall high concordance of zebrafish embryo assays with in vivo mammalian studies, false negative and false positive results have been reported. False negative results in risk assessment models are of particular concern for human safety, as developmental anomalies may be missed. Interestingly, for several chemicals and drugs that were reported to be false negative in zebrafish, skeletal findings were noted in the in vivo studies. As the number of skeletal endpoints assessed in zebrafish is very limited compared to the in vivo mammalian studies, the aim of this study was to investigate whether the sensitivity could be increased by including a skeletal staining method. Three staining methods were tested on zebrafish embryos that were exposed to four teratogens that caused skeletal anomalies in rats and/or rabbits and were false negative in zebrafish embryo assays. These methods included a fixed alizarin red-alcian blue staining, a calcein staining, and a live alizarin red staining. The results showed a high variability in staining intensity of larvae exposed to mammalian skeletal teratogens, as well as variability between control larvae originating from the same clutch of zebrafish. Hence, biological variability in (onset of) bone development in zebrafish hampers the detection of (subtle) treatment-related bone effects that are not picked-up by gross morphology. In conclusion, the used skeletal staining methods did not increase the sensitivity of zebrafish embryo developmental toxicity assays.